Source-grounded facts extracted from NOCOPI TECHNOLOGIES INC/MD/'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
NOCOPI TECHNOLOGIES INC/MD/ entered into Stock Purchase Agreements with various institutional investors valued at $400,000 (effective 2026-05-18).
“On May 18, 2026, the Company entered into Stock Purchase Agreements (the “ Stock Purchase Agreements ”), by and between the Company and various institutional investors (the “ Investors ”).”
Material Agreements
NOCOPI TECHNOLOGIES INC/MD/ entered into Asset Purchase Agreement with Polymeric Nocopi LLC, Polymeric U.S., Inc., Savara Capital valued at $2,650,000 (effective 2026-05-18).
“On May 18, 2026, Nocopi Technologies, Inc., a Maryland corporation (the “ Company ”), entered into an Asset Purchase Agreement (the “ Asset Purchase Agreement ”) with Polymeric Nocopi LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (“ Purchaser ”), Polymeric U.S., Inc., a Missouri corporation (the “ Seller ”) and Savara Capital, a Mauritius limited company and the sole shareholder of the Seller (“ Owner ”)”
M&A Transactions
NOCOPI TECHNOLOGIES INC/MD/ completed an acquisition involving Polymeric U.S., Inc. for $2,650,000 (closed 2026-05-18).
“contemplated thereby (the “ Closing ”) occurred simultaneously on May 18, 2026 (the “ Closing Date ”). Pursuant to the Asset Purchase Agreement, the aggregate consideration was $2,650,000 (the “ Purchase Price ”), which consisted of (a) $1,900,000 in cash (the “ Cash Consideration ”), subject to customary working capital adjustments and other reductions described”
Equity Issuances
NOCOPI TECHNOLOGIES INC/MD/ issued 266,666 shares of the Company’s common stock of common stock to various institutional investors (the "Purchasers") for $1.50 per share.
“The Purchase Agreements provide for the private issuance (the “ Private Placement ”) to the Purchasers of an aggregate of 266,666 shares of the Company’s common stock, par value $0.01 per share (the “ Common Stock ” and such shares of Common Stock issued pursuant to the Private Placement, the “ Placement Shares ”) at a purchase price of $1.50 per share.”
Material Agreements
NOCOPI TECHNOLOGIES INC/MD/ entered into Registration Rights Agreements with certain of the Purchasers (effective 2025-12-31).
“In connection with the Purchase Agreements, on December 31, 2025, the Company entered into Registration Rights Agreements with certain of the Purchasers (the “ Registration Rights Agreements ”).”
Material Agreements
NOCOPI TECHNOLOGIES INC/MD/ entered into Stock Purchase Agreements with various institutional investors valued at approximately $0.4 million (effective 2025-12-31).
“On December 31, 2025, Nocopi Technologies, Inc., a Maryland corporation (the “ Company ”) entered into Stock Purchase Agreements (the “ Purchase Agreements ”), by and between the Company and various institutional investors (the “ Purchasers ”).”
Jacqueline J. Goldman resigned as Class I director at NOCOPI TECHNOLOGIES INC/MD/.
“On June 13, 2025, Jacqueline J. Goldman notified the Board of Directors (the “ Board ”) of Nocopi Technologies, Inc. (the “ Company ”) of her resignation as a Class I director, effective immediately.”
Kevin Westenburg was appointed as Class III Director at NOCOPI TECHNOLOGIES INC/MD/.
“appointed Mr. Westenburg as a Class III Director to fill an existing vacancy on the Board.”
Kevin Westenburg was appointed as President at NOCOPI TECHNOLOGIES INC/MD/.
“appointed Kevin Westenburg as President of the Company.”
Matthew C. Winger was appointed as Chairman and Chief Executive Officer at NOCOPI TECHNOLOGIES INC/MD/.
“On March 4, 2025, the Board appointed Matthew C. Winger as the Company’s Chairman of the Board and Chief Executive Officer (and principal executive officer), effective immediately, to fill the vacancy created by Mr. Liebowitz’s resignation.”
Michael S. Liebowitz resigned as Chairman and Chief Executive Officer at NOCOPI TECHNOLOGIES INC/MD/.
“On February 26, 2025, Michael S. Liebowitz notified the Board of Directors (the “ Board ”) of Nocopi Technologies, Inc. (the “ Company ”) of his resignation as Chairman of the Board and Chief Executive Officer of the Company, effective immediately.”
Joseph K. Raymond resigned as Director at NOCOPI TECHNOLOGIES INC/MD/.
“On January 19, 2024, Joseph K. Raymond notified the Board of Directors (the “Board”) of Nocopi Technologies, Inc. (the “Company”) of his decision to resign from the Company’s Board, and all committees thereof, effective as of January 22, 2024.”
Michael S. Liebowitz was appointed as Chief Executive Officer at NOCOPI TECHNOLOGIES INC/MD/.
“In connection with Michael S. Liebowitz’s appointment as Chief Executive Officer of Nocopi Technologies, Inc. (the “Company”), on October 19, 2023,”
Material Agreements
NOCOPI TECHNOLOGIES INC/MD/ entered into Stock Purchase Agreement with Frost Gamma Investments Trust valued at $5 million (effective 2023-09-11).
“On September 11, 2023, Nocopi Technologies, Inc., a Maryland corporation (the “ Company ”) entered into a Stock Purchase Agreement (the “ Purchase Agreement ”), by and between the Company and Frost Gamma Investments Trust (the “ Purchaser ”).”
Marc Rash resigned as Director at NOCOPI TECHNOLOGIES INC/MD/.
“On August 29, 2023, Mr. Marc Rash notified the board of directors of Nocopi Technologies, Inc. (the “Company”) of his resignation therefrom and from all committee positions thereof.”
Michael S. Liebowitz was appointed as Chief Executive Officer and Chairman of the Board at NOCOPI TECHNOLOGIES INC/MD/.
“On August 8, 2023, Michael S. Liebowitz, age 54, was appointed by the Company’s Board of Directors to serve as the Company’s Chief Executive Officer and Chairman of the Board effective August 18, 2023.”
Michael A. Feinstein resigned as Chief Executive Officer and Director at NOCOPI TECHNOLOGIES INC/MD/.
“On August 7, 2023, Dr. Michael A. Feinstein notified the Company’s Board of Directors that on August 18, 2023 he will tender his resignation to the Company’s Board of Directors as a director of Nocopi Technologies, Inc. (the “ Company ”) and as Chief Executive Officer and all other officer positions of the Company.”
Shareholder Votes
NOCOPI TECHNOLOGIES INC/MD/ shareholders approved Advisory Vote to Approve the Compensation of the Company's Named Executive Officers at the 2023-07-12 meeting.
“Proposal 3: Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers The following votes were cast with respect to Proposal 3. The proposal was approved. For Against Abstain Broker Non-votes 6,562,926 3,628 582 1,635,579”
Shareholder Votes
NOCOPI TECHNOLOGIES INC/MD/ shareholders approved Ratify Morison Cogen LLP as the Company’s Independent Registered Public Accounting Firm at the 2023-07-12 meeting.
“Proposal 2: Ratify Morison Cogen LLP as the Company’s Independent Registered Public Accounting Firm The following votes were cast with respect to Proposal 2. The proposal was approved. For Against Abstain Broker Non-votes 7,515,199 684,946 2,570 —”
Shareholder Votes
NOCOPI TECHNOLOGIES INC/MD/ shareholders approved Election of Directors at the 2023-07-12 meeting.
“Proposal 1: Election of Directors The following persons were elected to the Board of Directors to serve until the 2026 Annual Meeting of Stockholders or until their successors have been duly elected or appointed and qualified: Name Votes For Votes Against Votes Withheld Broker Non-votes Matthew C. Winger 6,563,627 3,499 10 1,635,579 Joseph K. Raymond 6,549,722 14,531 2,883 1,635,579”
Material Agreements
NOCOPI TECHNOLOGIES INC/MD/ terminated Business Loan Agreement with Santander Bank, N.A. (effective 2023-06-30).
“the Company’s request to terminate that certain Business Loan Agreement with Santander Bank, N.A. relating to the Company’s business line of credit was granted on June 30, 2023”
Debra Glickman was appointed as Chief Financial Officer at NOCOPI TECHNOLOGIES INC/MD/.
“On June 15, 2023, Debra Glickman, age 56, was appointed by the Company’s Board of Directors to serve as the Company’s Chief Financial Officer effective June 19, 2023.”
Rudolph A. Lutterschmidt resigned as Vice-President and Chief Financial Officer at NOCOPI TECHNOLOGIES INC/MD/.
“On June 15, 2023, Rudolph A. Lutterschmidt tendered his resignation to the Company’s Board of Directors as Vice-President and Chief Financial Officer of Nocopi Technologies, Inc. (the “ Company ”), effective June 19, 2023.”
Jacqueline J. Goldman was elected as director at NOCOPI TECHNOLOGIES INC/MD/.
“On January 11, 2023, Company’s Board elected Jacqueline J. Goldman as a Class I director to fill the newly created directorship on the Board, effective immediately.”
Philip B. White resigned as director at NOCOPI TECHNOLOGIES INC/MD/.
“On January 11, 2023, Philip B. White tendered to Nocopi Technologies, Inc. (the “Company”) his resignation as a director on the Company’s board of directors (the “Board”).”
Michael S. Liebowitz was appointed as Class I Director at NOCOPI TECHNOLOGIES INC/MD/.
“On October 7, 2022, the Nocopi Technologies, Inc. (the “Company”) board of directors (the “Board”) appointed Mr. Michael S. Liebowitz to the Board, as a Class I director, effective immediately.”
Matthew C. Winger was appointed as Executive Vice President of Corporate Development at NOCOPI TECHNOLOGIES INC/MD/.
“On September 26, 2022, the Company’s board of directors (the “Board”) approved the appointment of Matthew C. Winger as Executive Vice President of Corporate Development effective October 1, 2022.”
Matthew C. Winger was appointed as Class II Director at NOCOPI TECHNOLOGIES INC/MD/.
“On March 29, 2022, the Board of the Company voted to increase the size of its Board from four (4) to five (5) members and appointed Mr. Matthew C. Winger (the first MSL18 Holdings Designee) to the Board, as a Class II director, effective immediately.”
Joe Raymond was elected as member of the Board at NOCOPI TECHNOLOGIES INC/MD/.
“On October 21, 2021, Nocopi Technologies, Inc. Board of Directors (the “ Board ”) elected Joe Raymond to serve as a member of the Board.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.